Notalgia Paresthetica- Itchy Back Study
We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.
About Notalgia Paresthetica
Notalgia Paresthetica is a condition where the skin of the upper back becomes itchy, and there is often a darker patch of skin on the itchy area. This condition may be caused by a problem with the nerve cells that provide feeling to the skin of the upper back.
About the Study
The purpose of this study is to test the effectiveness and safety of the study drug Ameluz®, a topically applied gel compared to a placebo gel, along with photodynamic therapy.
Am I Eligible?
- Men or women between 18 and 80 years of age at the time of informed consent
- Moderate to severe itch due to Notalgia Paresthetica
- 6-month history of chronic itching in the middle to upper back due to Notalgia Paresthetica
What Should I Expect?
- oral medication BID for 12 weeks.
- 50:50 active medication to placebo for the first 8 weeks, and then all subjects will receive the active study drug next 4 weeks.
- Participation will last approximately 5 months and includes 9 visits.
- Compensation available for time/travel
If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.